20.
uropathogenic bacteria and have related this response to the pattern of degranulation provoked by a variety of soluble and particulate agents. PMN were isolated from peripheral blood by dextran sedimentation and centrifugation through Ficoll-Hypaque followed by hypotonic sodium chloride lysis of remaining erythrocytes. Cells 6106 /ml) were then incubated with each stimulant at 37 C for up to 1 h, and after centrifugation for 15 s at 11 OOOg, the supernatants were aspirated and assayed for myeloperoxidase and neutral proteinase activity (azurophil granule markers), vitamin B12-binding protein (specik granule marker), N-acetylglucosaminidase (tertiary granule marker) and lactate dehydrogenase (cytoplasmic marker).
Unopsonized zymosan (1 mg/ml and 10 mg/ml), serumtreated zymosan (1 mglml), latex beads ( 5 x lo9 beads/ml), N-formyl-methionyl-leucyl-phenylalanine (fMLP; 1 0 yM ), concanavalin A (500pg/ml), phorbol myristate acetate ( l y~) and ionophore A23187 (5yM) all induced high release (>20%) of the specific granule marker but low or negligible release of proteins from the azurophil or tertiary granules (Fig. 1) . A non-fimbriate urinary isolate of Escherichia coli (strain AB) also induced selective release of the specific granule marker whether it was pretreated with serum or unopsonized. Conversely, an E. coli isolate (strain 504) possessing type 1 (mannose-sensitive) fimbriae provoked a unique response by releasing > 2% of marker proteins from all three types of granule irrespective of whether the bacteria were serum-treated or unopsonized. Measurements of lactate dehydrogenase confirmed these results to be due to degranulation rather than to gross cell damage.
The observations suggest that bacterial surface structures, such as type 1 fimbriae, may be largely responsible for determining the outcome of bacteria-PMN interactions. This work also supports the hypothesis that bacterial stimulation of enzyme release from the azurophil or tertiary granules of PMN could contribute to the tissue damage which precedes renal scarring. distinct mechanisms of cell activation have been identified (Hallett & Campbell, 1983) , one dependent, the other independent of an increase in intracellular free Ca2+.
There is no method presently available to determine whether neutrophils at the inflammatory site have already been activated in situ to produce reactive oxygen metabolites. In addition, the further characterization of the Ca2+-dependent secretory mechanism requires incorporation into the cells of specific inhibitors of granule-plasma membrane fusion. Markers of granule proteins would enable the past history of cells present in the inflammatory site to be determined,
The aim of the present study was the production of monoclonal antibodies to neutrophil granule antigens on the: (1) outer membrane surface, (2) inner membrane surface, (3) soluble components, e.g. myeloperoxidase. These would provide the specific reagents required to achieve these objectives.
Human neutrophils were prepared from the buffy coat from 5.7 litres of fresh blood by dextran sedimentation and centrigugation through Ficoll-Hypaque (Holt et al., 1984) . The purified neutrophils ( 5 x 10') were resuspended in 250 mM -sucrose and homogenized with a Polytron (max. speed for 30 s). The homogenate was centrifuged at lOOOg for 2 min to remove cell debris and nuclei. The supernatant containing granules was diluted with 0.2 M-sodium acetate, 1 M-sodium chloride, pH 4, and incubated for 1 h (room temperature) in order to extract the myeloperoxidase. This was followed by centrifugation at 30000g for 10min. The pellet containing the neutrophil granule membranes was separated from the supernatant containing the soluble granule components including myeloperoxidase. These two fractions were used as antigens for monoclonal antibody production.
The method for the production of monoclonal antibodies was essentially the same as that described by Kohler & Milstein (1975) . Female Balb/c inice were injected intraperitoneally with 250pg of protein in Freund's complete adjuvant. Sixteen days later the mice were injected with a further 250 pg of protein in phosphate-buffered saline (PBS), pH 7. Blood samples were taken 4 days later (rectoorbitally) in order to determine the presence of circulating antibodies. The same day the spleens were removed, the spleen cells isolated and fused with a mouse myeloma cell line Sp2/0-Ag14 by using 50% polyethylene glycol in the ratio 6 : 1.
Antibody-secreting hybridomas were detected by a twosite immunoradiometric assay (IRMA) for IgG. This assay used a solid-phase sheep antimouse IgG (SaM I&). Binding of mouse IgG from the hybridoma supernatant was detected by using a second antibody, I'25-labelled SaM IgC.
After an incubation period of 1 h (room temperature) the solid phase was filtered and the radioactivity determined with an automated gamma counter (Kemtek 3000). This method detected 22 antibody-secreting clones (Fig. la) .
An assay for antibodies specific to neutrophil granule antigens was also developed by using an 1'25-labelled second antibody with the granule membrane preparation as the solid-phase antigen.
The cellular localization of binding of antibodies from hybridoma supernatants was determined in order to further establish the specificity of these antibodies. Hybridoma supernatants were incubated with fixed neutrophils for 10min. After washing with PBS, fluorescein-labelled SaM IgC was added for a further 10min. After washing with PBS the binding of antibody was determined by fluorescence microscopy. Antibodies to two types of antigen were found: (1) a neutrophil intracellular component, (2) a plasma-membrane component on monocyte, lymphocytes and neutrophils (Fig. lb) . Hybridomas producing antibodies of both types were cloned by limiting dilution on a spleen cell-feeder layer. Screening of clones showed that four monoclonal antibodies had been produced, one of which bound to the plasma membrane and the others to intracellular antigens, consistent with the distribution of neutrophil granules.
Monoclonal antibodies to antigens in human neutrophil granules have not previously been reported. It is now necessary to characterize which antigens they react with and to use them as key reagents for establishing the role of neutrophil activation in the pathogenesis of inflammatory diseases. a-Foeto-protein (AFP) is an oncodevelopmental protein, the measurement of which is clinically useful in the investigation of various tumours and in the antenatal detection of foetal neural tube defects.
Conventionally, radioimmunoassay (RIA) has been used to measure AFP, but enzyme-linked immunosorbent assays (ELISA) have a number of advantages associated with them. Classically, ELISA is performed by allowing the specimen containing antigen (Ag) to react with an immbolized antibody (Ab). Subsequently an antibody-enzyme conjugate (AbE) is allowed to react with the bound antigen. The amount of bound AbE is measured by a chromogenic reaction. This is a two-stage ELISA. By allowing the antigen to react with immobilized antibody in the presence of AbE, Abbreviations used: AFP, a-foeto-protein; RIA, radioimmunoassay; ELISA, enzyme-linked immunosorbent assay; Ag, antigen; Ab, antibody; AbE, antibody-enzyme conjugate.
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We have investigated the kinetics of two-stage and onestage ELISA and have established methods for the measurement of serum AFP. Results obtained by these ELISA methods have been compared with those obtained by conventional RIA.
Radioimmunoassay of AFP was performed by incubating 50p1 of test, standard or control sera with 1001.11 of anti-AFP (Scottish Antibody Production Unit, Law Hospital, Scotland, U.K.) and loop1 of iodinated AFP (provided by Ninewells Hospital, Dundee, Scotland U.K.) for 2 4 h at room temperature. After incubation, 6 0 0~1 of polyethylene glycol (1 1.2%, w/v, in barbitone buffer, pH 8.6) was added, the tubes left standing for a further hour before being centrifuged at 3000g for 30min. The supernatant was aspirated and the bound fraction counted in a gamma counter.
The principles of the two-stage ELISA have been given in detail elsewhere (Macdonald et al., 1979) . Briefly the assay involved immobilizing anti-AFP (Dako Immunoglobulins, Copenhagen, Denmark) on the wells of plastic microtitre plates. After washing and drying of the plates by shaking, loop1 of standard, test or quality control
